CompanyDrug

Q1 2023 financial report: AstraZeneca leads innovation in China, Sanofi’s sales in China decline

CompanyDrug

CMS Receives NMPA Approval for Clinical Study of Tetravalent BsAb for nAMD

CompanyDrug

Sirnaomics’ RV-1730 Receives FDA Clearance for Phase I COVID-19 Vaccine Booster Trial

CompanyDeals

Reforgene Medicine Secures Pre-Series B Funding to Advance Thalassemia Gene Therapy

CompanyDeals

Zai Lab Partners with MediLink Therapeutics to Develop YL212 DLL3 ADC

CompanyDrug

Jiangsu Hengrui’s Vunakizumab for Plaque Psoriasis Accepted for Review by NMPA

CompanyDeals

OBiO Technology and ImmVira Partner on Oncolytic Virus Project for BLA Filing and Commercialization

CompanyDrug

SynerK Achieves Milestone with First Patient Dosing in Phase I siRNA Clinical Trial

Company

CSPC Pharmaceutical Group Reports 11% YOY Revenue Growth in 2022 Financial Results

CompanyDrug

Roche’s Q1 2023 Report: 3% Dip in Revenues with Strong Growth in Pharmaceuticals

Company

GSK Reports Q1 2023 Revenue Dip Amid COVID-19 Treatment Decline, Underlying Growth

CompanyDrug

SinoMab’s SM03 Meets Primary Endpoint in Phase III Rheumatoid Arthritis Trial